Cargando…
Targeting genetic alterations in protein methyltransferases for personalized cancer therapeutics
The human protein methyltransferases (PMTs) constitute a large enzyme class composed of two families, the protein lysine methyltransferases (PKMTs) and the protein arginine methyltransferases (PRMTs). Examples have been reported of both PKMTs and PRMTs that are genetically altered in specific human...
Autores principales: | Copeland, R A, Moyer, M P, Richon, V M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579158/ https://www.ncbi.nlm.nih.gov/pubmed/23160372 http://dx.doi.org/10.1038/onc.2012.552 |
Ejemplares similares
-
Protein methyltransferase inhibitors as precision cancer therapeutics: a decade of discovery
por: Copeland, Robert A.
Publicado: (2018) -
Methyltransferase-like proteins in cancer biology and potential therapeutic targeting
por: Qi, Ya-Nan, et al.
Publicado: (2023) -
Protein Arginine Methyltransferases as Therapeutic Targets in Hematological Malignancies
por: Sauter, Camille, et al.
Publicado: (2022) -
CARM1 arginine methyltransferase as a therapeutic target for cancer
por: Santos, Margarida, et al.
Publicado: (2023) -
Protein arginine methyltransferases: promising targets for cancer therapy
por: Hwang, Jee Won, et al.
Publicado: (2021)